We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $114B Turnover 39.14%
1-Year Est. Return 35.47%
 

Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.

This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.47%
3 Year Est. Return
+152.7%
5 Year Est. Return
+193.18%
10 Year Est. Return
+740.37%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 24.01%
2 Financials 15.45%
3 Communication Services 14.64%
4 Consumer Discretionary 9.68%
5 Technology 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZTS icon
1
Zoetis
ZTS
$34.8B
$310M 3.8%
7,515,997
+2,214,206
+42% +$103M
2013 Q2
9 quarters
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.47T
$178M 2.19%
+5,575,920
New +$180M
2015 Q3
0 quarters
AGN
3
DELISTED
Allergan plc
AGN
$176M 2.17%
648,837
+250,094
+63% +$76.8M
2014 Q2
5 quarters
TMUS icon
4
T-Mobile US
TMUS
$174B
$170M 2.09%
4,277,441
+327,918
+8% +$13.1M
2013 Q2
9 quarters
SHW icon
5
Sherwin-Williams
SHW
$83.7B
$130M 1.6%
1,754,604
+979,275
+126% +$85.9M
2013 Q2
9 quarters
AZO icon
6
AutoZone
AZO
$53.3B
$118M 1.45%
163,482
+77,459
+90% +$54.9M
2013 Q2
9 quarters
CMCSA icon
7
Comcast
CMCSA
$89.6B
$116M 1.42%
4,069,756
-1,248,950
-23% -$37.1M
2013 Q2
9 quarters
GILD icon
8
Gilead Sciences
GILD
$210B
$102M 1.25%
1,036,927
+883,381
+575% +$98.1M
2014 Q1
6 quarters
PFE icon
9
Pfizer
PFE
$160B
$98.8M 1.21%
3,314,705
+1,356,085
+69% +$43.5M
2014 Q1
6 quarters
NKE icon
10
Nike
NKE
$53.9B
$94.9M 1.17%
1,543,084
+90,384
+6% +$5.11M
2014 Q1
6 quarters
LBTYK icon
11
Liberty Global Class C
LBTYK
$3.36B
$92.8M 1.14%
2,606,688
+504,186
+24% +$20.4M
2013 Q2
9 quarters
CVS icon
12
CVS Health
CVS
$104B
$88.4M 1.09%
915,997
+88,016
+11% +$9.25M
2014 Q2
5 quarters
CHTR icon
13
Charter Communications
CHTR
$15.9B
$78.4M 0.96%
445,678
+254,171
+133% +$46.4M
2015 Q1
2 quarters
VZ icon
14
Verizon
VZ
$191B
$77M 0.95%
1,770,715
+1,730,542
+4,308% +$79.9M
2015 Q2
1 quarter
META icon
15
Meta Platforms (Facebook)
META
$1.58T
$76.5M 0.94%
850,905
-10,166
-1% -$933K
2014 Q1
6 quarters
MDT icon
16
Medtronic
MDT
$129B
$76.1M 0.93%
1,136,545
-131,311
-10% -$9.7M
2014 Q3
4 quarters
JNJ icon
17
Johnson & Johnson
JNJ
$656B
$75.6M 0.93%
809,433
+738,623
+1,043% +$71.5M
2014 Q1
6 quarters
LUV icon
18
Southwest Airlines
LUV
$23B
$75.2M 0.92%
1,976,518
+1,769,515
+855% +$65.3M
2014 Q4
3 quarters
ABT icon
19
Abbott
ABT
$181B
$72.7M 0.89%
1,807,936
+1,328,459
+277% +$62.6M
2014 Q1
6 quarters
COO icon
20
Cooper Companies
COO
$11.6B
$71.5M 0.88%
1,919,956
+243,724
+15% +$10.1M
2014 Q1
6 quarters
CAH icon
21
Cardinal Health
CAH
$64.3B
$65.8M 0.81%
857,148
+294,530
+52% +$24.6M
2014 Q2
5 quarters
LYB icon
22
LyondellBasell Industries
LYB
$18.9B
$64M 0.79%
767,487
-69,182
-8% -$6.15M
2013 Q2
9 quarters
LAZ icon
23
Lazard
LAZ
$4.23B
$63.8M 0.78%
1,472,265
+514,931
+54% +$26.5M
2014 Q1
6 quarters
C icon
24
Citigroup
C
$194B
$61.5M 0.76%
1,240,434
+13,430
+1% +$734K
2013 Q2
9 quarters
BMY icon
25
Bristol-Myers Squibb
BMY
$122B
$61.3M 0.75%
1,035,673
+389,607
+60% +$24.7M
2014 Q3
4 quarters

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.